{
    "clinical_study": {
        "@rank": "124393", 
        "arm_group": {
            "arm_group_label": "normal men and women", 
            "description": "normal volunteers: young and older men and women studied under fed and fasting (62.5h) conditions with frequent blood sampling for ghrelin and related hormones"
        }, 
        "brief_summary": {
            "textblock": "The overall objective of this study is to determine the extent to which circulating ghrelin\n      levels (total and bioactive ghrelin) are regulated by nutritional state and age."
        }, 
        "brief_title": "Effect of Fasting on Ghrelin and Growth Hormone in Healthy Young and Older Adults", 
        "completion_date": {
            "#text": "December 2004", 
            "@type": "Actual"
        }, 
        "condition": "Aging", 
        "detailed_description": {
            "textblock": "Normal volunteers: young and older men and women studied under fed and fasting (total 62.5h)\n      conditions, frequent blood sampling for ghrelin and other related hormones"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Healthy young (ages 18-30) and older (ages > 60) men and women with a body mass index\n        (BMI) of <35 kg/m2.  Young and older subjects will be matched for BMI.\n\n        Exclusion Criteria:\n\n          1. A history of coronary artery disease, congestive heart failure, peripheral vascular\n             disease, diabetes mellitus, significant hypertension (BP >180 systolic or >100\n             diastolic at rest); renal, hepatic, pulmonary disease; untreated hypothyroidism,\n             untreated hyperthyroidism; history of seizure disorder; history of malignancy (other\n             than some skin cancers), history of active chronic infections (e.g., HIV,\n             tuberculosis):  abnormal screening laboratory tests.  This information will be\n             obtained through the use of screening labs, history and physical exam and the medical\n             record.  See the GCRC protocol for details of the labs.\n\n          2. Hematocrit < 41% men, < 38% women\n\n          3. History of daily tobacco use within past 3 months\n\n          4. Chronic alcohol abuse\n\n          5. Recent weight change of > 10 pounds in last 3 months\n\n          6. Strenuous exercise for average of more than 60 min/day\n\n          7. Investigational drug within past 6 weeks\n\n          8. Any history of major psychosis, severe depression, anorexia nervosa\n\n          9. Transmeridian travel within 2 weeks prior to or during study -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "normal volunteers"
            }
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01922973", 
            "org_study_id": "10619"
        }, 
        "intervention": {
            "arm_group_label": "normal men and women", 
            "description": "normal volunteers fast from food on one occasion for 62.5 h; on another occasion fed 3 meals", 
            "intervention_name": "Fasting", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Hormones"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ghrelin", 
            "growth hormone", 
            "aging", 
            "normal volunteers"
        ], 
        "lastchanged_date": "August 12, 2013", 
        "number_of_groups": "1", 
        "official_title": "Effect of Fasting on Ghrelin and Growth Hormone in Healthy Young and Older Adults", 
        "overall_official": {
            "affiliation": "University of Virginia", 
            "last_name": "Michael O Thorner, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2004", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Ghrelin concentration", 
            "safety_issue": "No", 
            "time_frame": "24-h mean"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01922973"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Virginia", 
            "investigator_full_name": "Michael Thorner, MD", 
            "investigator_title": "Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Virginia", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Virginia", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2003", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}